You are an expert Named Entity Recognition (NER) system. Label all identifiable…
- User
System: You are an expert Named Entity Recognition (NER) system. Label all identifiable entities, abstract concepts, and meaningful ideas in the provided input text, emphasizing relevance to the financial domain.
Ensure the following: Label All Meaningful Entities: Identify every meaningful entity related to financial analysis, economic dynamics, or market contexts. Define New Concepts as Needed: Introduce and define entity types for abstract financial concepts or industry-specific terms not typically found in standard NER tasks. Provide an Exhaustive Entity List: Include every relevant label mentioned in the input text.
Answer in the following format: | | <description of entity group/concept>, | | <description of entity group/concept>, ...
Here is an Example : Input: Lawmakers continue to try to police social media use among teens — but Meta, parent company to Facebook, Instagram, and Threads, is pushing another group of companies to do the security work. Meta is expected to announce a proposal on Nov. 15 that will push for tech giants like Google and Apple to carry a bigger burden in keeping teenagers off of potentially harmful platforms. Meta's vision is that these companies, which manage app stores such as the Apple App Store and Google Play Store, require parental approval for teenagers aged 13 to 15 to download applications, according to a report by The Washington Post.
Output: Lawmakers | Regulatory agents | Individuals or groups responsible for creating and enacting laws, often influencing economic and regulatory environments.
social media | Digital Channel | Online media channels for content sharing and user interaction, particularly influential in advertising and consumer engagement. Meta | Company | Parent company of Facebook, Instagram, and Threads, involved in social media and technology sectors.
Facebook | Company | Social media platform owned by Meta, significant player in digital advertising and social media markets.
Instagram | Company | Photo and video sharing social media platform owned by Meta, influential in marketing and consumer engagement.
Threads | Company | Social media platform owned by Meta, contributing to the digital communication landscape.
Nov. 15 | Date | Specific date relevant for financial or regulatory announcements, potentially impacting market perceptions. tech giants | Major Companies | Entities that hold substantial market power in the technology sector. Google | Company | Technology company known for its search engine and digital services, significant in advertising and app distribution.
Apple | Company | Technology company known for its hardware and software products, influential in consumer technology and app distribution.
bigger burden | Operational Challenge | heightened difficulties or obstacles impacting a company’s operations, often resulting in resource strain or inefficiencies. Apple App Store | Platform | Digital distribution platform for applications on Apple devices, relevant for app market dynamics.
Google Play Store | Platform | Digital distribution platform for applications on Android devices, important for app market dynamics.
Parental approval | Concept | Regulatory measure proposed to manage access to applications by minors, impacting technology and social media usage.
The Washington Post | Newspaper | News outlet providing reports and analysis, influential in shaping public opinion and regulatory discourse. User: NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that preliminary results of the Phase I NATHALI-01 clinical trial evaluating UCART20x22 in patients with relapsed or refractory non-Hodgkin lymphoma (r/r NHL) and updated results of the Phase I BALLI-01 clinical trial evaluating UCART22 in pat Assistant: - Assistant
NEW YORK | Location | A major financial and economic hub, impacting global markets and finance sectors. Nov. 02, 2023 | Date | Specific date relevant for financial or corporate announcements, potentially impacting market perceptions. GLOBE NEWSWIRE | News Distribution Service | Platform for distributing press releases to the financial community. Cellectis | Company | Clinical-stage biotechnology company focused on gene-editing platform development for cell and gene therapies. Euronext Growth | Stock Exchange | European stock exchange where Cellectis is listed, relevant for trading and investment activities. NASDAQ | Stock Exchange | American stock exchange where Cellectis is also listed, significant for trading and technological investment. clinical-stage | Business Stage | Phase in a company's lifecycle focused on clinical trials and development of medical products. biotechnology | Industry | Sector focused on the use of biological systems or organisms in technological advancements and drug development. gene-editing platform | Technology | Innovative scientific technology used for altering genetic material, significant in biotechnology. cell and gene therapies | Medical Product | Treatments developed to modify or manipulate cells and genes for therapeutic benefit. Phase I NATHALI-01 clinical trial | Clinical Trial | Early-stage clinical study evaluating a specific treatment's safety and efficacy. UCART20x22 | Drug | Gene-edited cellular therapy candidate under clinical evaluation. relapsed or refractory non-Hodgkin lymphoma (r/r NHL) | Medical Condition | Type of cancer being targeted by specific clinical treatments. Phase I BALLI-01 clinical trial | Clinical Trial | Early-stage clinical study focused on evaluating another specific treatment's safety and efficacy. UCART22 | Drug | Another gene-edited cellular therapy candidate under clinical evaluation.